show episodes
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
  continue reading
 
Artwork

1
ASA Biopharm's Podcast

American Statistical Association (ASA) Biopharm. Section

Unsubscribe
Unsubscribe
Monthly
 
In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
  continue reading
 
Artwork

1
BioBoss

John Simboli

Unsubscribe
Unsubscribe
Monthly
 
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
  continue reading
 
Pharmacokinetic and Biopharmaceutics from the University of Oklahoma College of Pharmacy - PDF files of course material, Audio AND Video tutorials PHAR 7633 - Description and quantitation of factors affecting the absorption, distribution, and metabolism, and excretion of drugs. Development of appropriate dosage regimens and graphical analysis of drug concentration data sets. Bioequivalence and drug product testing. Drug analysis in biological matrix.
  continue reading
 
Stock Day Media is the top source for Penny and Micro-Cap news in America. Our Mission is to provide transparency to publicly traded companies and inform the investors directly. Our reach in the stock market community gives Stock Day the ability to find new potential investors that are seeking unique and lucrative opportunities.
  continue reading
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
I’m an electrical engineer who enjoys listening to and sharing stories of ordinarily extraordinary women that work in STEM fields. The women featured on these episodes work in different STEM fields, are at different phases in their careers, and bring their unique perspectives and stories. I am endlessly fascinated by what these women do, how they have navigated their careers, balanced families, and why they made the career choices they did. Most STEM fields are dominated by men which makes f ...
  continue reading
 
Artwork

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
Monthly
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Artwork

1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado

Unsubscribe
Unsubscribe
Weekly+
 
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
  continue reading
 
Loading …
show series
 
In this insightful episode, we explore the cutting-edge field of glycoengineering and its transformative impact on biopharmaceutical drug design. Join us as we chat with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, to uncover the nuances of chemoenzymatic glycogen engineering and its potential to rev…
  continue reading
 
Navidea Biopharmaceuticals, Inc. (OTC: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the company’s pivotal NAV3-33 clinical trial. Dr. Michael Blue, Navidea’s Chief Medical Officer, said "Results are not indicativ…
  continue reading
 
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved dru…
  continue reading
 
In this episode of the Stock Day Media Podcast, host interviews Josh Sodiatis, CEO of Peer to Peer Network (Mobi Card). Josh announces two major updates: the company's approval for crowdfunding via a FINRA-registered intermediary, allowing unaccredited investors to invest as little as $250, and a legal opinion ruling Mobi Coin as a utility token. H…
  continue reading
 
How do small biotech companies make strategic decisions with limited resources? This episode dives deep into the art of prioritization and outsourcing to achieve success. Join us as we speak with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, a seasoned biotech scientist with years of experience in both large and small bi…
  continue reading
 
This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's…
  continue reading
 
Are you navigating the complex world of bioprocess CMC development and manufacturing in a small biotech company? Our latest episode is a must-listen! Join us as we sit down with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, who shares invaluable insights on overcoming the unique challenges faced by small biotech firms. I…
  continue reading
 
We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…
  continue reading
 
Husqvarna, the world leader in robotic lawnmowing and part of Husqvarna Group, is proud to partner with Liverpool Football Club - one of the most iconic football clubs in the world. As part of the multi-year global agreement, Husqvarna will become the official groundskeeping partner of Liverpool FC, the first partnership of its kind for both partie…
  continue reading
 
Scheid Vineyards Inc. (OTC Markets: SVIN) announced its financial results for the fiscal year ended February 29, 2024. Scott Scheid, President and CEO, commented, "As has been widely reported in the media, the wine industry has faced considerable challenges this past year. This year we've been faced with selling bulk wine at below cost and, consequ…
  continue reading
 
This week on Biotech Nation, Dr. Marianne De Backer, CEO of Vir Biotechnology talks about their Phase 2 clinical trials targeting hepatitis B and D co-infections. Vir's approach uses two drugs: tobevibart (an antibody) and elebsiran (an siRNA). These drugs prevent the virus from entering liver cells and stop it from replicating. Preliminary results…
  continue reading
 
Kalpana Pot is an actor, writer, host, and space communicator. Renowned for her vibrant online presence, particularly in space science, Kalpana has cultivated a platform with over 200K followers on Instagram and 4.4 million likes on TikTok. Importantly, she challenges the prevailing narratives about women in STEM, a perspective not often encountere…
  continue reading
 
The World Economic Forum projects that by 2050, climate change could cause 14 million additional deaths and $12 trillion in global healthcare costs. And this will exacerbate global health inequities with our most vulnerable populations, including women, youth, elderly, lower-income groups, and hard-to-reach communities bearing the brunt of this cha…
  continue reading
 
Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company, and IASO Biotechnology, a biopharmaceutical company, jointly announced the agreement on a series of cooperation, including IASO Bio's purchase from Innovent regarding its relevant right of FUCASO® (Equecabtagene Autoleucel), as well as Innovent's equity investment in I…
  continue reading
 
Uncover the hidden science behind creating safer, more effective biological drugs! Dive into glycoanalytics and glycoengineering, the secret weapons revolutionizing biopharma. Join us as we talk with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, who breaks down the complexities of glycosylation and it…
  continue reading
 
We love to hear from our listeners. Send us a message. Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's three phase 1 programs combine T-cell science with a proprietary drug delivery device to target solid tumors, specifically metastatic breast, non-small-cell lung, and castrate-resistant prostate cancers. …
  continue reading
 
NuRAN Wireless Inc. (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RN), a leading supplier of mobile and broadband wireless infrastructure solutions, is pleased to announce the financial close of the US $5M Loan Facility with the Facility for Energy Inclusion, a fund managed by Cygnum Capital. This important financing allowing the company to focus on building more…
  continue reading
 
Join us as we explore the pivotal role of process mapping in biotech knowledge management. Our guest, Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, shares invaluable insights into leveraging technology to streamline operations. Key Insights: Identifying Critical Process Knowledge: Learn…
  continue reading
 
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…
  continue reading
 
Laredo Oil, Inc. (OTC Pink Sheets: LRDC), announces that Hell Creek Crude, LLC, a wholly-owned subsidiary of Laredo Oil, commenced drilling the Reddig 11-21 well in the Midfork field located in Valley County, Montana . This well is the first of three production wells planned to be drilled and operated by HCC in the Midfork field. BlockQuarry Corp. …
  continue reading
 
DEEPX, a pioneering AI semiconductor technology company led by CEO Lokwon Kim, has made history as the first AI semiconductor company in the world to be invited to the World Economic Forum. This esteemed gathering of global economic leaders took place at the Summer Davos Forum in Dalian, China, from June 25-27. The 15th edition of this prestigious …
  continue reading
 
Want to turn your biotech chaos into streamlined success? Learn from expert Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, on how process mapping can transform your knowledge management and elevate your business performance. Key Takeaways: Eliminate Scope Creep: Learn how to maintain foc…
  continue reading
 
We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…
  continue reading
 
Drug-induced seizures are a major concern for central nervous system active pharmaceuticals during development. Currently, there are no guidelines for interrogating and mitigating seizure liability associated with new pharmaceuticals. Because of the risks to patient safety during clinical trials, the understanding of nonclinical characterization th…
  continue reading
 
PCS Edventures!, Inc. (OTCPK: PCSV), a leading provider of K-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced results of operations for its fiscal year ended March 31, 2024. Revenue was $9.1 million compared to $7.0 million in revenue for the same period last year. The Company ended its fiscal year wi…
  continue reading
 
Q Precious and Battery Metals Corp. (CSE:QMET) is pleased to announce that construction of drill pads and access routes has commenced on the La Corne South project located north of Val d'Or, Quebec. The drill sites were designed to sample multi-element Volcanic Massive Sulphide targeted from geophysical survey and from historic diamond drilling res…
  continue reading
 
Hydrogen Technologies, a wholly owned subsidiary of Jericho Energy Ventures Inc. (TSXV:JEV)(OTC PINK:JROOF)(FRA:JLM), is pleased to announce that it has successfully tested its patented, next generation Dynamic Combustion Chamber (DCC™) boiler burner at the Ohio facility of Selas Heat Technology Company LLC, one of HT's partners for its DCC™ boiler…
  continue reading
 
Get ready to dive into the fascinating world of cryopreservation! In this episode, we welcome Mark Davison, an experienced entrepreneur and CEO of Grant Instruments, leaders in laboratory equipment, to explore the intricate science of freezing and thawing cells. Mark brings his wealth of experience to demystify this crucial process, revealing how c…
  continue reading
 
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.By Moira Gunn
  continue reading
 
iQSTEL Inc. (OTC-QX: IQST) a US-based, publicly listed telecommunications and technology company preparing for a Nasdaq up-listing revealed next stage plans for accelerated revenue growth and profit expansion beyond its recently announced $290 million 2024 annual revenue forecast. In 2023, the company reported revenue growth of approximately 55% dr…
  continue reading
 
In this episode of the Stock Day Media Podcast, the host interviews Dennis Calvert, CEO of BioLargo, a company focused on solving environmental problems, particularly clean water issues. Calvert discusses BioLargo's efforts to tackle contaminants like micro pollutants and PFAS, emphasizing the health risks posed by these "forever chemicals." He exp…
  continue reading
 
HammerPay, a wholly-owned subsidiary of Hammer Fiber Optics Holdings Corp. (OTC Pink: HMMR), has revamped its cash-in process for the UBA Remit Wallet - powered by HammerPay in Liberia. Customers can now deposit funds without any fees, a move aimed at driving platform adoption and usage. Greene Concepts Inc. (OTC Pink: INKW) is pleased to announce …
  continue reading
 
Picture a world where we can freeze cells and bring them back to life perfectly intact. In this episode, we're joined by Mark Davison, a leading expert in cryopreservation and CEO of Grant Instruments to uncover the intricate science of freezing and thawing cells. From basic principles to advanced techniques, we delve into how cryopreservation is r…
  continue reading
 
We love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns that kept a largely aged patient population from setting fo…
  continue reading
 
Pan American Energy Corp. ( CSE: PNRG | OTCQB: PAANF | FRA: SS60 ) is pleased to announce the completion of the Spring 2024 field prospecting and sampling program at the Big Mack Lithium Project, located 80 km north of the town of Kenora, Ontario. The exploration program is part of a collaborative research project with the Institute of Microbial Sy…
  continue reading
 
Nevada Canyon Gold Corp. (OTC Markets: NGLD) is pleased to announce it has signed, through its wholly owned subsidiary, Nevada Canyon, LLC, a binding Purchase Agreement to acquire a 2% net smelter returns royalty on the Pikes Peak Project, located in Mineral County, Nevada. CubicFarm® Systems Corp. (TSXV: CUB) , a leading agricultural technology co…
  continue reading
 
Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company announced that clinical data of IBI363 (first-in-class PD-1/IL-2 α-bias bispecific antibody fusion protein) in advanced solid tumors are presented at the 2024 ESMO Virtual Plenary. Fifty 1 Labs, Inc. (OTCPK: CAFI), a holding company that operates in the sports supplemen…
  continue reading
 
Could sound waves be the revolutionary key to gene therapy manufacturing? In this episode, Gabriel Dumy, CTO and Co-founder at Kolibri, reveals how acoustic waves are set to transform cell harvesting and gene transfection processes, making biomanufacturing more efficient and less damaging to cells. Kolibri is a company revolutionizing the way we gr…
  continue reading
 
This week we have a best of rerun with Dr. Mark Sumeray from Amolyt Pharma. Dr. Sumeray talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.…
  continue reading
 
To learn more about BCLA’s events and consulting visit https://www.bc-la.org/ To learn more about UCLA Anderson School of Management visit https://www.anderson.ucla.edu/ Follow our Instagram @insidebiotech for updates about episodes and upcoming guests! To learn more about BCLA’s events and consulting visit our website. Follow BCLA on LinkedIn…
  continue reading
 
CNB Community Bancorp, Inc. (OTCQX:CNBB) announced that the Board of Directors has declared a quarterly cash dividend on the Company's common stock in the amount of $0.29 per share, consistent with the dividend paid for the 2nd Quarter of 2023. SLB (NYSE: SLB) and Aker Carbon Capture (ACC) announced today the closing of their previously announced j…
  continue reading
 
Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) is pleased to announce that it has entered into a non-binding Letter of Intent to acquire 100% of the issued and outstanding share capital of a leading solventless cannabis brand, Port North Extracts Inc. Golden Triangle Ventures, Inc. (OTC PINK: GTVH) is excited to announce it has received financia…
  continue reading
 
Are sound waves the key to revolutionizing gene therapy? In this groundbreaking episode, we sit down with Gabriel Dumy, CTO and Co-founder at Kolibri, a company revolutionizing the way we grow and engineer cells at scale using acoustic waves. Gabriel shares the challenges facing modern bioproduction and unveils an exciting solution that's setting t…
  continue reading
 
We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …
  continue reading
 
Positron Corporation (OTC: POSC), a leading molecular imaging medical device company offering Positron Emission Tomography/Computed Tomography (PET and PET-CT) imaging systems and clinical services, is pleased to announce its membership in the national alliance Cardiac PET Industry Coalition, an organization at the forefront of quality of patient c…
  continue reading
 
In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to seri…
  continue reading
 
Atrium Mortgage Investment Corporation (TSX: AI) is pleased to announce that its board of directors has declared a dividend for the month of June 2024 of $0.075 per common share, to be paid July 12, 2024 to shareholders of record June 28, 2024. Atrium pays monthly dividends currently at an annual rate of $0.90 per share Fusion92, a marketing transf…
  continue reading
 
The Fannie Mae (OTCQB: FNMA) Home Purchase Sentiment Index ® (HPSI) decreased 2.5 points in May to 69.4 as the component measuring consumer attitudes toward homebuying conditions fell markedly, reaching an all-time survey low. This month, only 14% of consumers indicated that it's a good time to buy a home, down from 20% last month, while the share …
  continue reading
 
Dive into the future of bioprocessing with Nils Brechmann, Marketing Manager at MAGic BioProcessing and co-inventor of the process applications, as we explore how magnetic bead technology is transforming downstream processing. MAGic BioProcessing is a biotech company from Uppsala, Sweden, that develops magnetic-based recovery of biologicals. Key Ta…
  continue reading
 
This week Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, discusses advanced health tech. Dr. Kraft highlights his use of wearables like the Apple Watch, Oura ring, and non-invasive blood pressure monitors. He also introduces "otherables," which track health without being worn, using devices like cameras and modified WiFi. These technolog…
  continue reading
 
Loading …

Quick Reference Guide